Food and Drug Regulation in an Era of Globalized Markets

Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today’s markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India.

From the changing nature of packaged and processed food supply chains, to the reorientation of pharmaceutical research and funding coalesced to confront firms, regulators, and consumers are now faced with previously unknown challenges.

Based on the 2014 O’Neill Institute Summer program, this book provides an international, cross-disciplinary look at the changing world of regulations and offers insights into requirements for successful implementation.

Interdisciplinary approach allows readers to understand the varying perspectives involved in regulatory developmentIncludes case studies to highlight harmonization efforts and challenges, and to provide practical insights for application going forwardProvides a thorough assessment of supply chains, potential gaps, and means of anticipating and addressing issuesPresents a comprehensive snapshot of changes in the food safety law in the United States and under international standards, including academic, industry and regulatory perspectivesAddresses conflicts and cooperation between relevant US agencies including USDA, FDA, DEA, EPA, FTC and the Department of Commerce

• Foreword;
• Introduction;
• Part I: Convergence and Divergence in Regulatory Regimes;
• Part II: Challenges Accompanying the Globalization of Pharmaceutical Supply Chains;
• Part III: Challenges Accompanying the Diversification and Globalization of Food Sources and Additives;
• Part iv: Challenges in Emerging and Middle Income Markets